PatientsVille.com Logo


Decapeptyl - slow release Medical Research Studies

Up-to-date List of Decapeptyl - slow release Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Decapeptyl - slow release Medical Research Studies

Rank Status Study
1 Unknown  Adjusting Wheelchair Set-Up to Minimize Shoulder Joint Forces During Propulsion
Conditions: Paraplegia;   Upper Limb Pain
Outcome Measures: Peak shoulder joint forces;   Propulsion Speed;   Horizontal and Vertical Axle Placement
2 Not yet recruiting Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.
Conditions: Trigeminal Neuralgia (Burchiel Type I);   Trigeminal Neuralgia (Burchiel Type II);   Trigeminal Neuropathic Pain;   Trigeminal Deafferentation Pain;   Complex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity);   Glossopharyngeal Neuralgia;   Upper Extremity Pain Due to Deafferentation of the Cervical Spine;   Central Pain Syndromes
Intervention: Device: Epidural Motor Cortex Stimulation
Outcome Measure: Pain Assessments
3 Unknown  Multi Dimensional System for Evaluating a Preventive Program for Upper Extremity Disorders Among Computer Operators
Conditions: Musculoskeletal Disorders;   Upper Extremity Pain Chronic
Interventions: Behavioral: Ergonomic intervention;   Behavioral: Standard ergonomic intervention;   Behavioral: control group
Outcome Measures: Musculoskeletal disorders measurement (MSD score);   Rapid Upper Limb Assessment (RULA)score;   Kinematic Data [range of motion ( R.O.M) and angular velocity]measured by 3D motion analysis system.;   Muscle activity;   Psychosocial job characteristics assessment (DCSQ)
4 Recruiting The Effect of Integrated CAM Treatment in Hospitalized Patients
Conditions: Low Back Pain;   Neck Pain;   Knee Pain;   Shoulder Pain;   Intervertebral Disc Herniation;   Spinal Stenosis
Interventions: Drug: Herbal medicine;   Procedure: Acupuncture;   Procedure: Pharmacopuncture;   Procedure: Bee venom pharmacopuncture;   Procedure: Chuna manipulation
Outcome Measures: NRS of low back pain (LBP);   NRS of radiating leg pain;   NRS of neck pain;   NRS of radiating arm pain;   NRS of knee pain;   NRS of shoulder pain;   Oswestry disability index (ODI);   Vernon-Mior Neck Disability Index (NDI);   The Korean Western Ontario McMaster Index;   Shoulder Pain and Disability Index;   Physical and neurological examinations
5 Recruiting Freedom® Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease
Condition: Symptomatic Cervical Degenerative Disc Disease (DDD) From C3-C7
Intervention: Device: Freedom Cervical Disc
Outcome Measures: Safety of FCD;   Performance of FCD;   Incidence of AEs;   Neck/Arm Pain;   Neurological function;   Subject Function;   Radiographic Measurements;   Examine AEs
6 Recruiting A Focused Registry on Anterior Cervical Interbody Spacer ACIS
Condition: Degenerative Cervical Spine
Outcome Measures: Effect of neck pain on everyday life measured by the Neck Disability Index (NDI).;   Pain;   Handling details;   Length of Hospital Stay;   Adverse Events
7 Recruiting Biomechanical Validation of the Transfer Assessment Instrument (TAI)
Condition: Spinal Cord Injury
Outcome Measures: Transfer performance (TAI scores, biomechanical variables);   Upper limb pain (questionnaires);   Upper Limb Function and Balance Assessment
8 Unknown  Investigation of Acceptable Dose of Mobilisation and Tactile Stimulation to Enhance Upper Limb Recovery After Stroke
Condition: Stroke
Interventions: Behavioral: Conventional UK physical therapy (Con UK PT);   Behavioral: Con UK PT + 30 minutes/day Mobilisation & Tactile Stimulation (MTS);   Behavioral: Con UK PT + 60 minutes a day MTS;   Behavioral: Con UK PT + 120 minutes a day MTS
Outcome Measures: Efficacy: Primary outcome, Motricity Index – arm;   Efficacy: Action Research Arm Test (ARAT).;   Adverse events: Occurrence of upper limb pain and decrease Motricity score;   Underlying mechanisms: Functional MRI for suitable London subjects;   Underlying mechanisms: Transcranial magnetic stimulation to measure evoked motor potentials in paretic upper limb for suitable London subjects.
9 Recruiting The Post-operative Analgesia of the Virtual Reality Using a Mirror Therapy After Total Knee Arthroplasty
Conditions: Osteoarthritis, Knee;   Nociceptive Pain;   Virtual Reality Exposure Therapy
Intervention: Device: Mirrored Virtual reality
Outcome Measures: 6 minute walk test;   Visual analogue scale (VAS) while resting;   Visual analogue scale (VAS) while moving;   Active ROM of flexion and extension on the knee;   Tridol consumption per week;   WOMAC index;   Graded ambulation distances;   Timed-stands test;   Side effects
10 Unknown  Efficacy of Telerehabilitation Intervention Program Using Telebiofeedback Among Computer Operators
Condition: Work Related Musculoskeletal Disorders
Intervention: Device: surface electromyography
Outcome Measures: Posture at work environment measured by Rapid Upper LImb Assessment (RULA);   Musculoskeletal Disorders (MSD) - pain and inconvenience
11 Unknown  A Study to Test the Effectiveness of Mirror-Box and Mental Visualization Treatments on Phantom Limb Pain
Conditions: Amputation;   Phantom Limb;   Pain
Interventions: Device: mirror-box treatment;   Behavioral: Mental visualization
Outcome Measures: Significant decrease in the level of phantom limb pain at 4 weeks.;   Significant decrease in the number and duration of daily phantom limb pain episodes at 4 weeks.
12 Not yet recruiting The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic Neuropathy
Conditions: Diabetic Neuropathies;   Complex Regional Pain Syndrome Type II;   Resistant Peripheral Neuropathic Pain;   Chemotherapy Induced Pain Neuropathy
Intervention: Device: TDCS/sham procedure on five consecutive days
Outcome Measures: Changes in the amplitude of P300;   Changes in the Latency of P300;   Changes in Pain Intensity-will be calculated as the difference in scores on the 11-point numerical pain rating scale (0-10);   Changes in Pain Thresholds for Tactile and Thermal Stimuli will be calculated as the difference between ratings obtained form pain threshold measurements before- and after tDCS
13 Unknown  RCT :Thoracic Sympathetic Block for the Treatment of Complex Regional Pain Syndrome I of the Upper Limb
Condition: Complex Regional Pain Syndrome I of Upper Limb
Intervention: Procedure: thoracic sympathetic block
Outcome Measures: Analgesia after block;   analgesia quality of life
14 Recruiting Brachial Plexus Block in Post-Op Pain Control After Distal Upper Extremity Fracture: A Prospective Randomized Study
Condition: Pain
Intervention: Procedure: Brachial Plexus Nerve Block
Outcome Measure: Post-Operative Pain
15 Recruiting Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)
Conditions: Acute Lymphoblastic Leukemia;   Neuropathy;   Neuropathic Pain
Interventions: Drug: gabapentin;   Drug: placebo
Outcome Measures: Daily total dose of oral morphine (mg/kg/day).;   Pain scores right now;   Pain score during the previous 24 hours
16 Recruiting Surgical Positioning of the Arm During Thoracic Surgery -Effect on Shoulder Pain After Surgery?
Condition: Lung Cancer
Intervention: Procedure: Modified lateral positioning.
Outcome Measures: Postoperative shoulder pain after lung surgery.;   Pain medication;   White blood cell;   C reactive protein
17 Not yet recruiting Effective Screening for Pain Study
Conditions: Pain;   Pain Management
Interventions: Behavioral: NRS pain now;   Behavioral: PEG
Outcome Measures: Arm 1 (NRS now), to arm 2 (PEG), to arm 3 (usual care) pairwise difference scores in baseline and pain disability detection at one week, and satisfaction with pain management at one week;   Arm 1 (NRS now), to arm 2 (PEG), to arm 3 (usual care) pairwise differences in pain missingness and rating variability;   Arm 1 (NRS now), to arm 2 (PEG), to arm 3 (usual care) pairwise difference scores in baseline and pain disability detection at one week,
18 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
Outcome Measures: Relative Prolongation Ability Score for Gadolinium subdermally injected.;   Efficacy of Botox intramuscularly vs. subdermally in Upper Limb Spasticity.
19 Recruiting Single-arm Study to Assess the Safety of Hydromorphone HCl by Intrathecal Administration
Condition: Chronic Pain
Intervention: Drug: Hydromorphone Hydrochloride
Outcome Measure: Frequency of Adverse Events during a 12-month period of treatment with intrathecal hydromorphone.
20 Recruiting Care Management for the Effective Use of Opioids
Conditions: Low Back Pain;   Pain
Interventions: Drug: Analgesic and co-analgesic therapy;   Behavioral: Pain self-management/coping skills treatment
Outcome Measures: Brief Pain Inventory (BPI), includes BPI pain intensity score, BPI pain interference score and Roland Disability Scale;   Psychological distress (PHQ-9, GAD-7 Anxiety, VA PTSD Screener, AUDIT-C;   Opioid Misuse - Current Opioid Misuse Measure (COMM);   Generic HRQL (SF-12) measure of health status;   Pain Beliefs (Pain Catastrophizing Scale);   Patient Global Rating of Change (PGIC);   Opioid Dose;   Back Function (Functional Improvement);   Social Support Questionnaire (SSQ6)

These studies may lead to new treatments and are adding insight into Decapeptyl - slow release etiology and treatment.

A major focus of Decapeptyl - slow release research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Decapeptyl - slow release